Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 371960, 7 pages
http://dx.doi.org/10.1155/2015/371960
Research Article

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud’s Phenomenon

1Department of Clinical Science & Community Health, University of Milano, 20122 Milan, Italy
2Division of Rheumatology, Istituto Gaetano Pini, 20122 Milan, Italy
3Medical Statistics and Biometry, 20122 Milan, Italy
4Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano, 20122 Milan, Italy
5Rheumatology Unit, Ospedale Moriggia-Pelascini, 22015 Gravedona, Italy

Received 19 February 2015; Revised 2 May 2015; Accepted 4 May 2015

Academic Editor: Clelia M. Riera

Copyright © 2015 Francesca Ingegnoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Herrick, “The pathogenesis, diagnosis and treatment of Raynaud phenomenon,” Nature Reviews Rheumatology, vol. 8, no. 8, pp. 469–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Hirschl, K. Hirschl, M. Lenz, R. Katzenschlager, H.-P. Hutter, and M. Kundi, “Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance,” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1974–1981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Spencer-Green, “Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary disease,” Archives of Internal Medicine, vol. 158, no. 6, pp. 595–600, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. F. M. Wigley, “Raynaud's phenomenon,” Current Opinion in Rheumatology, vol. 5, no. 6, pp. 773–784, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Ingegnoli, P. Boracchi, R. Gualtierotti et al., “Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy,” Rheumatology, vol. 49, no. 4, pp. 797–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. M. Wigley, “Raynaud's phenomenon,” The New England Journal of Medicine, vol. 347, no. 13, pp. 1001–1008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Maverakis, F. Patel, D. G. Kronenberg et al., “International consensus criteria for the diagnosis of Raynaud's phenomenon,” Journal of Autoimmunity, vol. 48-49, pp. 60–65, 2014. View at Google Scholar
  8. B. Chikura, T. L. Moore, J. B. Manning, A. Vail, and A. L. Herrick, “Sparing of the thumb in Raynaud's phenomenon,” Rheumatology, vol. 47, no. 2, pp. 219–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Chikura, T. Moore, J. Manning, A. Vail, and A. L. Herrick, “Thumb involvement in Raynaud's phenomenon as an indicator of underlying connective tissue disease,” Journal of Rheumatology, vol. 37, no. 4, pp. 783–786, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. G. Kallenberg, “Raynaud's phenomenon as an early sign of connective tissue diseases,” VASA. Supplementum, vol. 34, pp. 25–28, 1992. View at Google Scholar
  11. S. N. Lambova and S. I. Kuzmanova, “Raynaud's phenomenon in common rheumatic diseases,” Folia medica, vol. 48, no. 3-4, pp. 22–28, 2006. View at Google Scholar · View at Scopus
  12. F. Ingegnoli, R. Gualtierotti, C. Lubatti et al., “Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations,” Seminars in Arthritis and Rheumatism, vol. 38, no. 4, pp. 289–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Ingegnoli, R. Gualtierotti, C. Lubatti et al., “Nailfold capillary patterns in healthy subjects: a real issue in capillaroscopy,” Microvascular Research, vol. 90, pp. 90–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Agmon-Levin, J. Damoiseaux, C. Kallenberg et al., “International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 17–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. F. van den Hoogen, D. Khanna, J. Fransen et al., “2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative,” Arthritis and Rheumatism, vol. 65, no. 11, pp. 2737–2747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. C. Sharp and P. C. Anderson, “Current concepts in the classification of connective tissue diseases. Overlap syndromes and mixed connective tissue disease (MCTD),” Journal of the American Academy of Dermatology, vol. 2, no. 4, pp. 269–279, 1980. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Petri, A.-M. Orbai, G. S. Alarcõn et al., “Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 64, no. 8, pp. 2677–2686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. C. Shiboski, C. H. Shiboski, L. A. Criswell et al., “American College of rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort,” Arthritis Care and Research (Hoboken), vol. 64, no. 4, pp. 475–487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Aletaha, T. Neogi, A. J. Silman et al., “Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Arthritis & Rheumatism, vol. 62, no. 9, pp. 2569–2581, 2010. View at Google Scholar
  20. E. C. LeRoy and T. A. Medsger Jr., “Raynaud's phenomenon: a proposal for classification,” Clinical and Experimental Rheumatology, vol. 10, no. 5, pp. 485–488, 1992. View at Google Scholar · View at Scopus
  21. E. Vittinghoff and C. E. McCulloch, “Relaxing the rule of ten events per variable in logistic and cox regression,” American Journal of Epidemiology, vol. 165, no. 6, pp. 710–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. R. Hocking and C. L. Leslie, “Selection of the best subset in regression analysis,” Technometrics, vol. 9, no. 4, pp. 531–540, 1967. View at Google Scholar · View at MathSciNet
  23. L. G. Suter, J. M. Murabito, D. T. Felson, and L. Fraenkel, “The incidence and natural history of Raynaud's phenomenon in the community,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1259–1263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Hirschl and M. Kundi, “Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology,” The Journal of Rheumatology, vol. 23, no. 2, pp. 302–309, 1996. View at Google Scholar · View at Scopus
  25. R. De Angelis, F. Salaffi, and W. Grassi, “Raynaud's phenomenon:prevalence in an Italian population sample,” Clinical Rheumatology, vol. 25, no. 4, pp. 506–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. H. R. Maricq, P. H. Carpentier, M. C. Weinrich et al., “Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison,” The Journal of Rheumatology, vol. 24, no. 5, pp. 879–889, 1997. View at Google Scholar · View at Scopus
  27. J. A. Block and W. Sequeira, “Raynaud's phenomenon,” The Lancet, vol. 357, no. 9273, pp. 2042–2048, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Planchon, M.-A. Pistorius, P. Beurrier, and P. de Faucal, “Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients,” Angiology, vol. 45, no. 8, pp. 677–686, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Koenig, F. Joyal, M. J. Fritzler et al., “Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis,” Arthritis and Rheumatism, vol. 58, no. 12, pp. 3902–3912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. De Angelis, P. Del Medico, P. Blasetti, and C. Cervini, “Raynaud's phenomenon: cinical spectrum of 118 patients,” Clinical Rheumatology, vol. 22, no. 4-5, pp. 279–284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Pavlov-Dolijanovic, N. S. Damjanov, N. Z. V. Stupar, G. L. Radunovic, R. M. Stojanovic, and D. Babic, “Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients,” Rheumatology International, vol. 33, no. 4, pp. 921–926, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Csiki, L. Galuska, I. Garai et al., “Raynaud's syndrome: comparison of late and early onset forms using hand perfusion scintigraphy,” Rheumatology International, vol. 26, no. 11, pp. 1014–1018, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Hughes, T. Moore, N. O'Leary et al., “A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders,” Rheumatology, 2015. View at Publisher · View at Google Scholar
  34. V. D. Steen, “Autoantibodies in systemic sclerosis,” Seminars in Arthritis and Rheumatism, vol. 35, no. 1, pp. 35–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Hudson, M. Mahler, J. Pope et al., “Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis,” Journal of Rheumatology, vol. 39, no. 4, pp. 787–794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Hanke, C. S. Brückner, C. Dähnrich et al., “Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients,” Arthritis Research & Therapy, vol. 11, no. 1, article R22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Mehra, J. Walker, K. Patterson, and M. J. Fritzler, “Autoantibodies in systemic sclerosis,” Autoimmunity Reviews, vol. 12, no. 3, pp. 340–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Mehra, M. Hudson, M. Mahler, M. Baron, and M. Fritzler, “Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?” Rheumatology International, vol. 34, no. 3, pp. 425–427, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hudson, J. Pope, M. Mahler et al., “Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis,” Arthritis Research and Therapy, vol. 14, no. 2, article R50, 2012. View at Publisher · View at Google Scholar · View at Scopus